Eversept Partners, LP - ORCHARD THERAPEUTICS PLC ownership

ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 74 filers reported holding ORCHARD THERAPEUTICS PLC in Q4 2021. The put-call ratio across all filers is 0.76 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of ORCHARD THERAPEUTICS PLC
ValueSharesWeighting
Q1 2022$298,742
-46.1%
419,5810.0%0.02%
-34.3%
Q4 2021$553,847
-57.7%
419,581
-26.3%
0.04%
-61.5%
Q3 2021$1,310,036569,5810.09%
Other shareholders
ORCHARD THERAPEUTICS PLC shareholders Q4 2021
NameSharesValueWeighting ↓
CHI Advisors LLC 2,931,185$12,047,0004.29%
RA Capital Management 12,315,213$50,616,0000.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 6,949,416$28,562,0000.70%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 620,233$2,549,0000.35%
Casdin Capital, LLC 1,870,000$7,686,0000.34%
Vivo Capital, LLC 1,325,736$5,449,0000.32%
Bleichroeder LP 250,000$1,028,0000.18%
Virtus ETF Advisers LLC 40,292$166,0000.09%
Forefront Analytics, LLC 30,369$123,0000.06%
PLATINUM INVESTMENT MANAGEMENT LTD 411,977$1,693,0000.04%
View complete list of ORCHARD THERAPEUTICS PLC shareholders